Sector Alpha Week of 2026-08-14
Sector Alpha — machine-written from the numbers · Data as of 2026-08-14

Bajaj Consumer Care Ltd

BAJAJCON
FMCG - Personal Care

Bajaj Consumer Care Ltd's price has outrun its earnings. +123.8% in a year against EPS +59.3% — the market is paying now for delivery later.

The sharpest disagreement: the price moved +123.8% in a year while annual EPS moved +59.3% — the difference is re-rating, and re-rating has to be repaid with earnings.

The price is in a confirmed uptrend (56 weeks in) while the P/E sits at the 86th percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +86.8% year on year, and 80% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.

Stage
Turning around
fundamental trajectory, 12 quarters
Price
₹501
+123.8% 1Y
P/E
29.3×
86th pctile
of its own 11-year range
Revenue (Jun 26)
₹342 Cr
+25.3% YoY
Profit (Jun 26)
₹71.0 Cr
+86.8% YoY
Operating margin
24.0%
+9.0 pp YoY
ROCE
30%
FY26
ROIC
55.2%
vs WACC 12.0% → +43.2 pp
Cash conversion
80%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Bajaj Consumer Care Ltd trades at ₹501, in a confirmed uptrend and 56 weeks into that stage. That is +13.4% against its own 200-day average. It sits at 61% of a 52-week range of ₹239 to ₹670. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (5 weeks and counting).

Today the stock is in a confirmed uptrend — week 56 of stage 2, confirmed. At ₹501 it trades +13.4% versus its 200-day average and sits at 61% of its 52-week range (₹239–₹670).

Aug 26: ₹501 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+13.4% versus the 200-day line, week 56 of stage 2
Price50-day avg200-day avg
S2S4S2₹711₹562₹413₹264₹114₹501₹442Aug 23May 24Feb 25Dec 25Aug 26
S2S4S2₹711₹562₹413₹264₹114₹501₹442Aug 23Feb 25Aug 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (553 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Feb 16Aug 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +33% while the NIFTY 500 moved +284% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (5 weeks and counting; last ahead the week of 2026-07-10) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Bajaj Consumer Care Ltd trades at 29.3× P/E, at the pricey end of its own range (86th percentile). Its long-run median P/E is 22.2×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 29.3× is at the pricey end of its own range (86th percentile), against a long-run median of 22.2× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 29.3× vs a 22.2× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.5-year window; loss-period spikes above 38× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (86th percentile)
P/EMedianEPS (TTM) (quarterly)
40.8×₹18.532.2×₹13.823.6×₹9.215.1×₹4.66.5×₹0.0×29.30×₹17Feb 16Oct 18Jun 21Feb 24Aug 26
40.8×₹18.532.2×₹13.823.6×₹9.215.1×₹4.66.5×₹0.0×29.30×₹17Feb 16Jun 21Aug 26
PEG 0.41 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Computed here as quarter-end P/E ÷ trailing-twelve-month EPS growth (only quarters with positive growth), because a reported quarterly PEG is not held for this stock. Last 7 quarters; values above 6 pinned at the top.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
6.4×4.8×3.2×1.6×0.0××0.41×Q2 FY24Q3 FY24Q2 FY26Q3 FY26Q1 FY27
6.4×4.8×3.2×1.6×0.0××0.41×Q2 FY24Q2 FY26Q1 FY27
P/E
29.3×
86th percentile of 11y
PEG
1.30
derived from 3-year earnings growth

🚨 Why the multiple sits where it does: over the past year annual EPS moved +59.3% against a +123.8% price move — the price outran earnings, pushing the multiple UP its own range.

The price move, decomposed: over 5y, of the +13.8%/yr price move, ~+2.9%/yr came from earnings growth and ~+10.9 pp from the multiple (expanding); over 10y, of the +2.5%/yr price move, ~+0.9%/yr came from earnings growth and ~+1.6 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Turning around

Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Bajaj Consumer Care Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −18.2% at the trough to +77.0%, a 5-quarter improving streak, ROCE lifting at 35.6%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +20.7% in FY26, profit +52.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
23%66%15%42%6.8%18%−1.3%−6.4%−9.4%−31%%%20.7%52%FY16FY21FY26
23%66%15%42%6.8%18%−1.3%−6.4%−9.4%−31%%%20.7%52%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit accelerating
RevenueProfitEPS
27%94%19%63%11%33%2.2%2.6%−6.2%−28%%%25.1%77%85.2%Sep 23Dec 24Jun 26
27%94%19%63%11%33%2.2%2.6%−6.2%−28%%%25.1%77%85.2%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
37%32%27%23%18%%35.6%Sep 23Mar 24Dec 24Sep 25Jun 26
37%32%27%23%18%%35.6%Sep 23Dec 24Jun 26
Revenue growth
Rising
latest +25.1% · span −3.9% to +25.1%
Profit growth
Rising
latest +77.0% · span −19.4% to +77.0%
EPS growth
Rising
latest +85.2% · span −17.3% to +85.2%
ROCE
Rising
latest 35.6% · span 19.2%–35.6%

Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+20.7%+6.6%+4.8%+3.8%
Profit+52.0%+11.0%−3.2%−0.3%
EPS+59.3%+14.8%−0.8%+0.9%
Share price+123.8%+29.6%+13.8%+2.5%
Revenue YoY (Jun 26)
+25.3%
latest quarter vs a year ago
Profit YoY (Jun 26)
+86.8%
latest quarter vs a year ago
Revenue 10y
3.8%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

73.4/100 — rank 1 of 12 in FMCG - Personal Care · 100% evidence confidence

Bajaj Consumer Care Ltd scores 73.4 out of 100 against the 12 companies it is compared with in FMCG - Personal Care, ranking 1. Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.

The four contributions add to the total exactly: 32.3 + 16.9 + 10.2 + 14 = 73.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Bajaj Consumer Care Ltd reported ₹342 Cr of revenue in the Jun 26 quarter, +25.3% year on year. That is the 6th straight quarter of year-on-year growth. Over 10 years it has compounded at 3.8% a year. The last full year, FY26, came in at ₹1,165 Cr. The last four reported quarters add to ₹1,240 Cr.

FY26 revenue came in at ₹1,165 Cr (+20.7% on the year), capping 10 years at 3.8% compound. The latest quarter (Jun 26) printed ₹342 Cr, +25.3% year on year — the 6th consecutive quarter of year-over-year growth.

FY26 revenue ₹1,165 Cr (+20.7% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
3.8% a year over 10 years
RevenueYoY growth
1.3k23%94415%6296.8%315−1.3%0−9.4%₹ Cr%₹1,16520.7%FY16FY21FY26
1.3k23%94415%6296.8%315−1.3%0−9.4%₹ Cr%₹1,16520.7%FY16FY21FY26
Jun 26: ₹342 Cr (+25.3% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
6th straight quarter of growth
Revenue (quarterly)YoY growth
36934%27722%18511%92−0.6%0−12%₹ Cr%₹34225.3%Sep 23Dec 24Jun 26
36934%27722%18511%92−0.6%0−12%₹ Cr%₹34225.3%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +25.0% growth against the decade's 3.8% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +25.1% over the last 4 quarters against +13.7%/yr over the last 8 — accelerating; TTM profit +77.0% vs +23.6%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Bajaj Consumer Care Ltd's operating margin is 24.0% in the Jun 26 quarter, +9.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 13.0% to 34.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 24.0%, +9.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 13.0%–34.0%.

Why the margin moved: operating margin went +9.4 pp year on year while gross margin went +3.9 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY26: 19.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 13.0–34.0% band over 13 years
operating marginYoY change (pp)
36%7.0%30%3.5%24%0.0%17%−3.5%11%−7.0%%%19%6%FY14FY20FY26
36%7.0%30%3.5%24%0.0%17%−3.5%11%−7.0%%%19%6%FY14FY20FY26
Jun 26: 24.0% operating margin (+9.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
25%11%21%7.1%18%3.0%14%−1.1%10.0%−5.1%%%24%9%Sep 23Dec 24Jun 26
25%11%21%7.1%18%3.0%14%−1.1%10.0%−5.1%%%24%9%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Bajaj Consumer Care Ltd earned ₹71.0 Cr of net profit in the Jun 26 quarter, +86.8% year on year. It is the 5th consecutive quarter of growth. Full-year FY26 profit was ₹190 Cr. The 10-year compound rate is −0.3%. That is 20.8% of the quarter's revenue. The same quarter a year earlier earned ₹38.0 Cr.

Jun 26 profit was ₹71.0 Cr, +86.8% year on year — the 5th consecutive quarter of growth. On the full year, FY26 printed ₹190 Cr (+52.0%), and the 10-year compound rate is −0.3%.

FY26 profit ₹190 Cr (+52.0% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
−0.3% a year over 10 years
Net profitYoY growth
24158%18136%12014%60−7.9%0−30%₹ Cr%₹19052%FY16FY21FY26
24158%18136%12014%60−7.9%0−30%₹ Cr%₹19052%FY16FY21FY26
Jun 26: ₹71.0 Cr (+86.8% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
5th straight quarter of growth
Net profit (quarterly)YoY growth
77117%5878%3838%19−1.8%0−42%₹ Cr%₹7186.8%Sep 23Dec 24Jun 26
77117%5878%3838%19−1.8%0−42%₹ Cr%₹7186.8%Sep 23Dec 24Jun 26

Why profit moved: revenue contributed +25.3% and the margin +9.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.

Pace comparison, last four quarters: profit +77.2% vs revenue +25.0%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 80% of Bajaj Consumer Care Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹197 Cr of operating cash against ₹190 Cr of profit. After ₹158 Cr of capital spending, ₹39.0 Cr was left as free cash.

FY26: operating cash of ₹197 Cr against reported profit of ₹190 Cr, leaving free cash of ₹39.0 Cr after ₹158 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 80% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹197 Cr vs profit ₹190 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution.
80% of 3-year profit arrived as cash
Operating cashNet profitFree cash
256192128640₹ Cr₹197₹190₹39FY16FY21FY26
256192128640₹ Cr₹197₹190₹39FY16FY21FY26
FY26: CFO = 104% of profit (three-year rate 80%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
110%95%79%63%48%%104%FY16FY21FY26
110%95%79%63%48%%104%FY16FY21FY26

Why conversion sits at 80%: the cash cycle stretched 62 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 4.9× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Bajaj Consumer Care Ltd's cash conversion cycle runs 42 days in FY26, up from −20 days in FY21. Capital spending ran ₹172 Cr over the last 3 years. At FY26 sales of ₹1,165 Cr each day of that cycle holds about ₹3.2 Cr, so roughly ₹134 Cr sits inside the business at any moment.

FY26: debtors at 24 days, inventory at 52 days — roughly 1.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 42 days, looser than FY21's −20.

The full loop: cash goes out to suppliers and production on day 0; stock waits 52 days to sell; customers pay about 24 days after that; and suppliers themselves are paid at 34 days — netting out to the 42-day cycle.

In money terms: at FY26 sales of ₹1,165 Cr, each day of the cycle holds about ₹3.2 Cr — so the 42-day loop keeps roughly ₹134 Cr sitting inside the business at any moment.

FY26: a 42-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+62 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
11881447−30days42d52d24d34dFY14FY17FY20FY23FY26
11881447−30days42d52d24d34dFY14FY20FY26

On the investment side: capital spending of ₹172 Cr over the last 3 fiscal years against ₹35.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹27.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹158 Cr, work-in-progress ₹27.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
174116590−57₹ Cr₹158₹27FY16FY18FY21FY23FY26
174116590−57₹ Cr₹158₹27FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Bajaj Consumer Care Ltd earns a ROCE of 30% in FY26. That is up from a trough of 19% in FY25. Return on invested capital clears the cost of that capital by +43.2 percentage points, so growth here adds value rather than only size. The wiring behind it is 16.3% net margin on 1.23× asset turns.

FY26 ROCE is 30%, recovered from a FY25 trough of 19% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 16.3% net margin × 1.23× asset turns × 1.25× balance-sheet leverage ≈ 25.1% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 55.2% − 12.0% = a +43.2 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.

FY26: ROCE 30% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY25's 19%
ROCEROIC (annual)WACC
83%64%45%26%6.7%%30%50.8%FY14FY20FY26
83%64%45%26%6.7%%30%50.8%FY14FY20FY26
Q4 FY26: ROCE 26.7% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
64%50%36%22%8.2%%26.7%48.4%Q2 FY24Q3 FY25Q1 FY27
64%50%36%22%8.2%%26.7%48.4%Q2 FY24Q3 FY25Q1 FY27
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Bajaj Consumer Care Ltd carries total debt of ₹16.0 Cr against shareholder equity of ₹755 Cr as of Jun 26, a debt-to-equity of 0.02 — effectively unlevered. On the annual view that ratio went from 0.01 in FY23 to 0.02 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Jun 26: total debt of ₹16.0 Cr against shareholder equity of ₹755 Cr — a debt-to-equity of 0.02. On the annual view, debt-to-equity went from 0.01 (FY23) to 0.02 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹16.0 Cr at 0.02× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 4-year window.
Total debtDebt-to-equity
170.021×130.018×90.015×40.012×00.009×₹ Cr×₹160.02×FY23FY24FY26
170.021×130.018×90.015×40.012×00.009×₹ Cr×₹160.02×FY23FY24FY26
Jun 26: debt ₹16.0 Cr, debt-to-equity 0.02 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
190.032×150.026×100.020×50.014×00.008×₹ Cr×₹160.02×Sep 23Dec 24Jun 26
190.032×150.026×100.020×50.014×00.008×₹ Cr×₹160.02×Sep 23Dec 24Jun 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Promoters added 3.7 points of Bajaj Consumer Care Ltd over 8 quarters, the biggest move on the register. That takes promoters to 43.0% of the company. Domestic institutions moved −2.6 points over the same window, to 14.9%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Promoters: +3.7 points over 8 quarters to 43.0%; Domestic institutions: −2.6 points over 8 quarters to 14.9%; Foreign institutions: +2.0 points over 8 quarters to 16.1%.

Why the register moved: rotation — foreign institutions +2.0 points against domestic institutions −2.6 points over 8 quarters, with promoters +3.7 points — one class of institutions handing the register to the other, not a verdict change by the people closest to the numbers.

Fiscal-year ends: promoters +3.7 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
46%36%27%17%8.0%%43.0%16.6%14.3%26.2%Mar 24Mar 25Mar 26
46%36%27%17%8.0%%43.0%16.6%14.3%26.2%Mar 24Mar 25Mar 26
Promoters added 3.7 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
46%36%26%17%7.0%%43.0%16.1%14.9%26.0%Jun 23Dec 24Jun 26
46%36%26%17%7.0%%43.0%16.1%14.9%26.0%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Bajaj Consumer Care Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · FMCG - Personal Care
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Bajaj Consumer Care Ltdthis pageBAJAJCON 73.4/100Favorable setup100% evidence FADING 32.3/35 Revenue 25.1% · PAT 77% · OPM change 9 pp 100% evidence 16.9/25 ROCE 30% · OPM 24% 100% evidence 10.2/20 P/E 29.3× · PEG 1.64 100% evidence 14.0/20 RS sector 38.2% · RS bench 27.9% · 1Y 119.4%10 of 12 weeks ahead 100% evidence
Exact sum: 32.3 + 16.9 + 10.2 + 14 = 73.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2Marico LtdMARICO 67.0/100Favorable setup82% evidence FADING 25.8/35 Revenue 25.1% · PAT 15% · OPM change 1 pp 95% evidence 17.9/25 ROCE 47% · OPM 21% 76% evidence 5.8/20 P/E 59.5× · PEG — 50% evidence 17.5/20 RS sector 19.4% · RS bench 9.9% · 1Y 22.9%5 of 12 weeks ahead 100% evidence
Exact sum: 25.8 + 17.9 + 5.8 + 17.5 = 67 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3Gillette India LtdGILLETTE 66.4/100Favorable setup94% evidence ASLEEP 23.9/35 Revenue 8% · PAT 18.4% · OPM change -1 pp 100% evidence 18.6/25 ROCE 90.7% · OPM 29% 100% evidence 14.3/20 P/E 37.1× · PEG 1.7 100% evidence 9.6/20 RS sector -1.4% · RS bench -11.3% · 1Y -25.7%0 of 10 weeks ahead 70% evidence
Exact sum: 23.9 + 18.6 + 14.3 + 9.6 = 66.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Hindustan Unilever LtdHINDUNILVR 62.7/100Mixed-positive evidence100% evidence ASLEEP 24.7/35 Revenue 5.8% · PAT 38.3% · OPM change 0 pp 100% evidence 14.0/25 ROCE 28.4% · OPM 23% 100% evidence 17.6/20 P/E 44.2× · PEG 0.72 100% evidence 6.4/20 RS sector -2.9% · RS bench -10.9% · 1Y -13.1%0 of 12 weeks ahead 100% evidence
Exact sum: 24.7 + 14 + 17.6 + 6.4 = 62.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -2.9% and the one-year return is -13.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
5Dabur India LtdDABUR 51.3/100Mixed-positive evidence94% evidence ASLEEP 18.6/35 Revenue 7.4% · PAT 10.9% · OPM change 0 pp 100% evidence 14.6/25 ROCE 20.3% · OPM 20% 100% evidence 7.7/20 P/E 36.2× · PEG 5.04 100% evidence 10.4/20 RS sector 0.3% · RS bench -16.8% · 1Y -20.1%0 of 10 weeks ahead 70% evidence
Exact sum: 18.6 + 14.6 + 7.7 + 10.4 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Procter & Gamble Hygiene and Health Care LtdPGHH 49.8/100Mixed-negative evidence94% evidence ASLEEP 13.4/35 Revenue -1.6% · PAT -4.7% · OPM change -9 pp 100% evidence 18.3/25 ROCE 157% · OPM 19% 100% evidence 13.7/20 P/E 34.6× · PEG 1.77 100% evidence 4.4/20 RS sector -15.8% · RS bench -26.8% · 1Y -36.3%0 of 10 weeks ahead 70% evidence
Exact sum: 13.4 + 18.3 + 13.7 + 4.4 = 49.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
7Colgate-Palmolive (India) LtdCOLPAL 47.7/100Mixed-negative evidence94% evidence ASLEEP 11.0/35 Revenue 3.8% · PAT -3.3% · OPM change -2 pp 100% evidence 21.5/25 ROCE 108% · OPM 30% 100% evidence 5.5/20 P/E 39.4× · PEG 6.07 100% evidence 9.7/20 RS sector -1.5% · RS bench -8.8% · 1Y -10.3%0 of 10 weeks ahead 70% evidence
Exact sum: 11 + 21.5 + 5.5 + 9.7 = 47.7 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
8Emami LtdEMAMILTD 41.1/100Mixed-negative evidence100% evidence BASING 7.7/35 Revenue 2.8% · PAT -8.2% · OPM change -1 pp 100% evidence 14.3/25 ROCE 28.1% · OPM 22% 100% evidence 9.8/20 P/E 23.2× · PEG 2.99 100% evidence 9.3/20 RS sector -9.6% · RS bench -17.3% · 1Y -30%0 of 12 weeks ahead 100% evidence
Exact sum: 7.7 + 14.3 + 9.8 + 9.3 = 41.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Zydus Wellness LtdZYDUSWELL 38.0/100Mixed-negative evidence100% evidence FADING 11.2/35 Revenue 66.3% · PAT -42.5% · OPM change -1 pp 100% evidence 6.5/25 ROCE 4.9% · OPM 17% 100% evidence 6.1/20 P/E 73.3× · PEG 1.75 100% evidence 14.2/20 RS sector 15.4% · RS bench 6.1% · 1Y 31.8%9 of 12 weeks ahead 100% evidence
Exact sum: 11.2 + 6.5 + 6.1 + 14.2 = 38 · Decision use: Price leads the evidence: RS versus the benchmark is 6.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
10Jyothy Labs LtdJYOTHYLAB 33.9/100Adverse evidence100% evidence BASING 5.1/35 Revenue 3.9% · PAT -22.1% · OPM change -9 pp 100% evidence 13.2/25 ROCE 28.7% · OPM 8% 100% evidence 9.1/20 P/E 25.8× · PEG 5.24 100% evidence 6.5/20 RS sector -16.7% · RS bench -23.9% · 1Y -38.7%0 of 12 weeks ahead 100% evidence
Exact sum: 5.1 + 13.2 + 9.1 + 6.5 = 33.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Godrej Consumer Products LtdGODREJCP 33.4/100Adverse evidence100% evidence ASLEEP 15.6/35 Revenue 9.2% · PAT 3.3% · OPM change 0 pp 100% evidence 9.6/25 ROCE 18.8% · OPM 19% 100% evidence 3.2/20 P/E 46× · PEG 7.49 100% evidence 5.0/20 RS sector -10.9% · RS bench -18.2% · 1Y -21.2%0 of 12 weeks ahead 100% evidence
Exact sum: 15.6 + 9.6 + 3.2 + 5 = 33.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Polo Queen Industrial and Fintech LtdPQIF 34.3/100Thin evidence · provisional50% evidence 15.1/35 Revenue -25.8% · PAT -16.1% · OPM change 0.3 pp 53% evidence 7.7/25 ROCE 2.5% · OPM 7.6% 57% evidence 8.5/20 P/E 223× · PEG — 15% evidence 3.0/20 RS sector -54.8% · RS bench -58.4% · 1Y -57.6%0 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 15.1 + 7.7 + 8.5 + 3 = 34.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Bajaj Consumer Care Ltd's share price today?

Bajaj Consumer Care Ltd trades at ₹501, +123.8% over the past year. The company is valued at ₹6,539 Cr. The stock sits at 61% of its 52-week range of ₹239–₹670, +13.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 56 weeks in. — as of 14 August 2026.

What were Bajaj Consumer Care Ltd's latest quarterly results?

Bajaj Consumer Care Ltd reported revenue of ₹342 Cr and net profit of ₹71.0 Cr for the Jun 26 quarter. Revenue rose 25.3% and profit rose 86.8% year on year. Earnings per share were ₹5.42. The operating margin was 24.0%, 9.0 pp higher than a year earlier. — as of 14 August 2026.

What is Bajaj Consumer Care Ltd's revenue?

Bajaj Consumer Care Ltd reported revenue of ₹342 Cr in the Jun 26 quarter, +25.3% year on year. For the full FY26 fiscal year, revenue was ₹1,165 Cr (+20.7%). Over the last 10 years revenue compounded at 3.8% a year. — as of 14 August 2026.

What is Bajaj Consumer Care Ltd's profit?

Bajaj Consumer Care Ltd earned ₹71.0 Cr of net profit in the Jun 26 quarter, +86.8% year on year — the 5th straight quarter of growth. Full-year FY26 profit was ₹190 Cr. The operating margin ran 24.0% in the latest quarter. — as of 14 August 2026.

What is Bajaj Consumer Care Ltd's market cap?

Bajaj Consumer Care Ltd's market capitalisation is ₹6,539 Cr at a share price of ₹501. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.

What is Bajaj Consumer Care Ltd's P/E ratio?

Bajaj Consumer Care Ltd trades at a P/E of 29.3×, at the 86th percentile of its own 11-year range, against a long-run median of 22.2×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.

Does Bajaj Consumer Care Ltd pay a dividend?

Not in its latest year — Bajaj Consumer Care Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 11 of its last 13 reported fiscal years, so there is a history but no current dividend. — as of 14 August 2026.

Is Bajaj Consumer Care Ltd overvalued?

On its own history, Bajaj Consumer Care Ltd looks expensive: its P/E of 29.3× sits at the 86th percentile of its 11-year range (long-run median 22.2×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.

Is Bajaj Consumer Care Ltd growing?

Yes — Bajaj Consumer Care Ltd is growing: latest-quarter revenue +25.3% year on year, profit +86.8%, and the margin +9.0 pp at 24.0%. The 10-year compound rates are 3.8% (revenue) and −0.3% (profit). The earnings engine currently reads: improving — as of 14 August 2026.

How is Bajaj Consumer Care Ltd performing?

Bajaj Consumer Care Ltd is in a confirmed uptrend, 56 weeks in. Its latest quarter's revenue rose 25.3% and profit rose 86.8% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 5 weeks. This describes what the data did, not a rating. — as of 14 August 2026.

What stage is Bajaj Consumer Care Ltd in?

Turning around — profit growth swung from −18.2% at the trough to +77.0%, a 5-quarter improving streak, ROCE lifting at 35.6%. The read comes from the last 12 quarters of growth (revenue growth +25.1% latest, profit growth +77.0% latest, eps growth +85.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 14 August 2026.

Is Bajaj Consumer Care Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 56 of stage 2), trading +13.4% versus its 200-day average and at 61% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.

Is Bajaj Consumer Care Ltd beating the market?

Not lately — on a trailing-13-week view Bajaj Consumer Care Ltd is currently behind the NIFTY 500 (5 weeks and counting; last ahead the week of 2026-07-10), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +33% against the NIFTY 500's +284% — behind the index over the full window. — as of 14 August 2026.

Will Bajaj Consumer Care Ltd's share price go up?

This page publishes no price forecast for Bajaj Consumer Care Ltd. What it measures instead: the share price is ₹501, the price is in a confirmed uptrend 56 weeks in. Its P/E of 29.3× sits at the 86th percentile of its own 11-year range. — as of 14 August 2026.

Who owns Bajaj Consumer Care Ltd?

Promoters hold 43.0% of Bajaj Consumer Care Ltd, foreign institutions 16.1%, domestic institutions 14.9% and the public 26.0% (latest quarter). The biggest move on the register over the last two years: Promoters added 3.7 points over 8 quarters. — as of 14 August 2026.

Does Bajaj Consumer Care Ltd have too much debt?

No — Bajaj Consumer Care Ltd's debt-to-equity is 0.02, and operating profit covers the interest bill north of 100×. FY26 borrowings were ₹16.0 Cr against equity of ₹755 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.

What is Bajaj Consumer Care Ltd's capex?

Bajaj Consumer Care Ltd spent ₹172 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹158 Cr, with ₹27.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.

What is Bajaj Consumer Care Ltd's cash flow?

Bajaj Consumer Care Ltd generated ₹197 Cr of operating cash flow in FY26 and ₹39.0 Cr of free cash flow after ₹158 Cr of capital spending. Reported profit that year was ₹190 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 14 August 2026.

Is Bajaj Consumer Care Ltd's profit real cash?

Yes — over the last 3 fiscal years, 80% of Bajaj Consumer Care Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹197 Cr against reported profit of ₹190 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 14 August 2026.

Where is Bajaj Consumer Care Ltd in its business cycle?

Bajaj Consumer Care Ltd's FY26 operating margin was 19.0%, against a 13-year band of 13.0%–34.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 24.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.

What could break the Bajaj Consumer Care Ltd story?

The sharpest disagreement: the price moved +123.8% in a year while annual EPS moved +59.3% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.

Is Bajaj Consumer Care Ltd a stock worth studying right now?

This is not investment advice. The machine read: Bajaj Consumer Care Ltd's price has outrun its earnings. +123.8% in a year against EPS +59.3% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI